China’s Vaccine Maker Sinovac (CoronaVac) Secures $500m for Expansion
Sinovac Life Sciences Co., Ltd. (Sinovac), a subsidiary of Sinovac, has secured $500 million in funding for further development, capacity […]
0
Sinovac’s CoronaVac trial reauthorized by Anvisa: Phase 3 Clinical Trial Continues on
TrialSite recently reported that the Brazilian drug regulatory authority has halted the Sinovac (CoronaVac) COVID-19 vaccine trial, however days later […]
0
Brazil’s Drug Regulator ANVISA Halts Sinovac Phase 3 Vaccine Although Principal Investigator Declares Death Not Related to Study
ANVISA, Brazil’s drug regulatory, halted the Sinovac Phase 3 clinical trial testing the Chinese company’s COVID-19 vaccine after a volunteer […]
0
Sinovac Clinical Trials Halted in Brazil Due to Severe Adverse Event
In early September, the AstraZeneca/Oxford vaccine trials were put on temporary hold across all international testing sites due to a […]
0
Sinovac Cash Problems? Bangladesh Phase 3 Clinical Trial at Risk
Bangladesh’s health ministry has rejected calls by China’s Sinovac Biotech to co-finance a Phase 3 COVID-19 vaccine-focused clinical trial in […]
1
COVID-19 Vaccine Clinical Trials & Manufacturing Hub in Egypt: All Chinese with Sinopharm & Sinovac
Egypt reports via its Minister of Higher Education and Scientific Research that that influential Arabic nation will conduct two Phase […]
0
Phase 3 CoronaVac Trial in Indonesia Moves Along while BPOM Plans an Audit of Sinovac Facility in China
Thus far, Indonesian authorities report the relatively smooth running of the Phase 3 Sinovac COVID-19 clinical trial vaccine candidate. Conducted […]
0
Leading Korean CRO Selected to Run Sinovac Phase 3 COVID-19 Vaccine Trial in Bangladesh
A leading Korean contract research organization (CRO) called LSK Global Pharma Services will conduct the Phase 3 clinical trial of […]
0
Indonesia Testing Location for China’s Sinovac Phase 3 Clinical Trial
Sinovac, one of the leading COVID-19 vaccine developers, initiated Phase 3 clinical trial in Indonesia where about 800 participants have […]
0
Indonesia Joins Sinovac to Initiate Phase 3 Testing of CoronaVac While Securing Option to Purchase 100m Doses
Indonesia’s Bio Farma, a state-run pharmaceutical company, plans to produce 100 million doses of COVID-19 vaccine product developed by Sinovac. In […]
0